Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver Disease

• Published in: The journal of clinical endocrinology and metabolism Vol. 108; no. 11; pp. 2907 - 2915
• Main Authors: Huang, Hangkai, Xie, Jiarong, Zeng, Yan, Liu, Zhening, Miao, Min, Xu, Lei, Xu, Chengfu
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 01.11.2023
• Subjects: Analysis; Cardiovascular diseases; Cholesterol; Fatty liver; High density lipoprotein; Lipids; Liver diseases; Low density lipoprotein; Low density lipoproteins; Medical research; Medicine, Experimental; Prognosis; Serum levels; Triglycerides; Type 2 diabetes; China; remnant cholesterol; prediction; nonalcoholic fatty liver disease; Nonalcoholic fatty liver disease
• DOI: 10.1210/clinem/dgad272
• ISSN: 0021-972X

Abstract Context Serum levels of remnant cholesterol have been reported to predict the prognosis of cardiovascular disease, independent of traditional lipid profiles. Objective This study aimed to explore the association between serum remnant cholesterol and the development of nonalcoholic fatty liver disease (NAFLD). Methods A total of 9184 adults who underwent physical examination annually were included in this study. The association between serum remnant cholesterol and incident NAFLD was analyzed by Cox proportional hazards regression. We evaluated the relative risk of NAFLD in the groups with discordant remnant cholesterol vs traditional lipid profiles using clinically relevant treatment targets. Results During a total of 31 662 person-years of follow-up, 1339 incident NAFLD cases were identified. In the multivariable-adjusted model, the fourth quartile of remnant cholesterol was positively associated with NAFLD risks compared with the first quartile (hazard ratio [HR]: 2.824; 95% CI, 2.268-3.517; P < .001). This association remained significant among individuals with normal levels of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (HR: 1.929; 95% CI, 1.291-2.882; P < .001). In individuals achieving the different treatment targets of LDL-C and non-HDL-C for risk stratification according to clinical guidelines, the association between remnant cholesterol and incident NAFLD was still significant. Conclusion Serum levels of remnant cholesterol have predictive value for the development of NAFLD beyond traditional lipid profiles.